HAEMONETICS CORPORATION
HAE US4050241003
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Strong Stewart W PR |
91.15 USD |
4,312 Sold |
393,039 USD |
26/07/2024 | 26/07/2024 |
| Lingamneni Anila EX VP |
90.00 USD |
79 Sold |
7,110 USD |
11/07/2024 | 12/07/2024 |
| Lingamneni Anila EX VP |
90.00 USD |
2,136 Sold |
192,240 USD |
11/07/2024 | 11/07/2024 |
| Strong Stewart W PR |
87.53 USD |
8,857 Sold |
775,253 USD |
28/05/2024 | 29/05/2024 |
| Basil Michelle L EX VP |
87.86 USD |
8,896 Sold |
781,603 USD |
28/05/2024 | 29/05/2024 |
| Basil Michelle L EX VP |
88.57 USD |
4,094 Sold |
362,606 USD |
28/05/2024 | 29/05/2024 |
| Strong Stewart W PR |
95.11 USD |
686 Sold |
65,245 USD |
17/05/2024 | 20/05/2024 |
| Basil Michelle L EX VP |
95.08 USD |
1,604 Sold |
152,508 USD |
17/05/2024 | 20/05/2024 |
| Llorens Josep EX VP |
95.08 USD |
987 Sold |
93,844 USD |
17/05/2024 | 20/05/2024 |
| Llorens Josep EX VP |
94.82 USD |
822 Sold |
77,942 USD |
17/05/2024 | 17/05/2024 |